Hatice Kübra Doğan

9PUBLICATIONS
14CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell metabolismCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 23, 2024
Anticancer Effect of Theranekron® on Androgen-Dependent Prostate Cancer Cells.

Yalçın Erzurumlu, Hatice Kübra Doğan, Deniz Çataklı

|Jan 17, 2024
New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling.

Yalcin Erzurumlu, Hatice Kubra Dogan, Deniz Catakli

|Jul 07, 2023
HERPUD1, a Member of the Endoplasmic Reticulum Protein Quality Control Mechanism, may be a Good Target for Suppressing Tumorigenesis in Breast Cancer Cells.

Yalçın Erzurumlu, Yağmur Doğanlar, Hatice Kübra Doğan

|May 02, 2023
Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells.

Yalcin Erzurumlu, Deniz Catakli, Hatice Kubra Dogan

|Apr 10, 2023
Circadian Oscillation Pattern of Endoplasmic Reticulum Quality Control (ERQC) Components in Human Embryonic Kidney HEK293 Cells.

Yalcin Erzurumlu, Deniz Catakli, Hatice Kubra Dogan

|Jan 25, 2023
Estrogens drive the endoplasmic reticulum-associated degradation and promote proto-oncogene c-Myc expression in prostate cancer cells by androgen receptor/estrogen receptor signaling.

Yalcin Erzurumlu, Hatice Kubra Dogan, Deniz Catakli

Pageof 2

Frequent Collaborators

8 joint publications

Yalçın Erzurumlu

7 joint publications

Deniz Çataklı

2 joint publications

İlter İlhan

1 joint publications

Meltem Özgöçmen